Wolverine Trading, LLC Acorda Therapeutics Inc Call Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$0.3 - $1.67 $3,390 - $18,871	-11,300 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.61 - $2.5 $3,864 - $6,000	-2,400 Reduced 17.52%	11,300 $19,000
Q4 2021 Feb 14, 2022	SELL	$2.3 - $4.71 $7,589 - $15,543	-3,300 Reduced 19.41%	13,700 $32,000
Q3 2021 Nov 12, 2021	BUY	$3.36 - $4.79 $57,120 - $81,430	17,000 New	17,000 $80,000
Q2 2021 Aug 06, 2021	SELL	$3.61 - $5.23 $38,627 - $55,961	-10,700 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$3.8 - $8.04 $40,660 - $86,027	10,700 New	10,700 $52,000

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.